Literature DB >> 8323989

Women with gastrointestinal symptoms: implications for nursing research and practice.

M M Heitkemper, M Jarrett, K A Caudell, E Bond.   

Abstract

Irritable bowel syndrome and functional bowel disorder are diagnoses used to describe chronic GI symptoms for which no overt pathological condition can be identified. Symptoms are more common in women and are frequently followed in gastroenterology clinics. The purpose of this article is to provide an overview of the research linking GI symptoms and reproductive cycling and to discuss implications for practice. GI symptoms such as stomach pain and nausea are highest during menses compared with other cycle phases; also, stool consistency is loosest at menses. This pattern is present in control subjects. In women with irritable bowel syndrome the same pattern is seen but with higher symptom intensity. Although animal studies have demonstrated that estrogen and progesterone modulate contractile function of some GI segments, in humans, symptoms are highest when these hormones are at the lowest levels. Thus, symptoms in women may be related to decreasing ovarian hormone levels or to other circulating hormones or factors which vary with the menstrual cycle. Additionally, other factors such as stress aggravate symptoms. Therapeutics directed toward increasing patient awareness of cyclic patterns in symptom complaints, for example, via the use of daily symptom diaries may be a useful adjunct to dietary, pharmacological, and other therapies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323989

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  2 in total

1.  Susceptibility to nausea and motion sickness as a function of the menstrual cycle.

Authors:  Robert L Matchock; Max E Levine; Peter J Gianaros; Robert M Stern
Journal:  Womens Health Issues       Date:  2008-05-15

Review 2.  Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.

Authors:  Mathieu Meleine; Julien Matricon
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.